Great announcement!
Certainly much better than if it was rejected haha!
It will be very interesting if the IER has to change now. I don’t logically see how it can recommend that it’s in our best interest to sell at 14.6 cents when they didn’t have this knowledge at the time of writing and can only add value to the company.
Interesting times ahead still.
- Forums
- ASX - By Stock
- Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
Great announcement! Certainly much better than if it was...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries